Brevan Howard Capital Management LP Care Dx, Inc. Transaction History
Brevan Howard Capital Management LP
- $11 Billion
- Q2 2024
A detailed history of Brevan Howard Capital Management LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 36,588 shares of CDNA stock, worth $1.14 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,588
Previous 11,501
218.13%
Holding current value
$1.14 Million
Previous $121,000
369.42%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CDNA
# of Institutions
157Shares Held
53.5MCall Options Held
60.8KPut Options Held
34.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.7MShares$178 Million0.81% of portfolio
-
Black Rock Inc. New York, NY5.29MShares$165 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$137 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.91MShares$122 Million1.02% of portfolio
-
Nikko Asset Management Americas, Inc.2.58MShares$80.4 Million0.47% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.67B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...